BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
9/03/2014 - NAD Recommends Virtua Health System Discontinue Challenged Claims for ‘Quad-Sparing’ Knee Replacement Surgery
The National Advertising Division has recommended that Virtua Health System discontinue certain advertising claims for the hospital chain’s minimally invasive, “quad-sparing” knee-replacement surgery. -
8/28/2014 - NAD Recommends Verizon Better Disclose Basis for Certain Claims following Cablevision Challenge
The National Advertising Division has recommended that Verizon Communications, Inc., modify certain advertising claims, including claims that are based on PC Magazine surveys, to better disclose the basis for the claims. -
8/27/2014 - NAD Finds P&G Can Support Certain Claims for Olay ‘Ultra Moisture Body Wash,’ But Recommends Company Discontinue ‘Lotion’ Claims
The National Advertising Division has determined that The Procter & Gamble Company can support claims that Olay Ultra Moisture Body Wash leaves more moisturizer on the skin than Dove Deep Moisture, a competing product made by Unilever United States, Inc. -
8/21/2014 - NAD Recommends Chobani Discontinue ‘Farmland’ Yogurt Commercial, Modify Facebook Ads
The National Advertising Division has recommended that Chobani, Inc., discontinue its “Farmland” commercials, the centerpiece of the company’s campaign to promote its “Simply 100” Greek yogurt, and modify certain online adverting. NAD noted, however, that the advertiser was entitled to promote its use of natural sweeteners as compared with the artificial sweeteners used by certain other yogurt brands. -
8/13/2014 - NAD Recommends eHarmony Discontinue Claims Challenged by Match.com
The National Advertising Division has recommended that eHarmony, Inc., discontinue certain “#1” advertising claims for the company’s dating website, eHarmony.com, including “#1 Most Marriages,” “#1 Most Enduring Marriages,” and “#1 Most Satisfying Marriages.” -
8/12/2014 - NAD Recommends ConAgra Modify or Discontinue ‘Steam, Not Lye’ Claim Challenged by Red Gold
The National Advertising Division has recommended that ConAgra Foods discontinue the claim “We peel our tomatoes with steam, not lye,” or modify the claim to make clear that lye-peeled tomatoes are neither unsafe nor unhealthy. -
8/06/2014 - NAD Finds Chattem Can Support Challenged Claims for ‘Nasacort’ Following Merck Challenge
The National Advertising Division has determined that sanofi-aventis, sanofi-aventis U.S. and Chattem, Inc., can support certain advertising claims for “Nasacort Allergy 24HR,” an over-the-counter allergy relief medication. The claims were challenged by MSD Consumer Care, Inc., a/k/a Merck Consumer Care. -
7/29/2014 - NAD Recommends US Postal Service Modify Website to Better Disclose Certain Insurance Restrictions; Postal Service Takes Steps to Do So
The National Advertising Division has recommended that the United States Postal Service better disclose to consumers the restrictions that apply to the claim “$50 insurance included in Priority Mail service.” -
7/29/2014 - NAD Recommends Fiore Rx Discontinue Claims for Company’s ‘Antifungal’ Nail Polish
In response to an inquiry from the National Advertising Division, Fiore Rx, LLC – the maker of Fiore Rx “Antifungal Nail Lacquer” – said it has modified or discontinued certain claims that reference the antifungal effects of its product on nails, as well as claims that reference the Food and Drug Administration (FDA). -
7/23/2014 - NAD Recommends ANTECH Discontinue Challenged Claims for Veterinary Diagnostic Test Following a Challenge by IDEXX
The National Advertising Division has recommended that ANTECH Diagnostics, Inc., the maker of the AccuPlex4 screening test for canine heartworm and tick-borne illnesses, discontinue advertising claims challenged by IDEXX Laboratories, Inc., the maker of the competing SNAP 4Dx Plus diagnostic test.